Streptococcus pneumoniae type 1 capsular polysaccharide antigen
Generic: Streptococcus pneumoniae type 1 capsular polysaccharide antigen·Brand: Pneumovax 23
Streptococcus pneumoniae type 1 capsular polysaccharide antigen: 1 clinical trial tracked.
Streptococcus pneumoniae type 1 capsular polysaccharide antigen evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about Streptococcus pneumoniae type 1 capsular polysaccharide antigen, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Clinical Trial Registry Records (1)
An Open-label, Single Arm, Multi-center Extension Study Evaluating Long-term Safety, Tolerability and Effectiveness of Ofatumumab in Subjects With Relapsing Multiple Sclerosis
Primary endpoint: Number of patients that experience an adverse event or abnormal laboratory, vital and/or ECG results and positive suicidiality outcomes
Interventionalopen1,882 targetStarted 2018-12Completion 2028-0950 sites · United StatesNovartis Pharmaceuticals